Work

Psychoradiological Biomarkers for Psychopharmaceutical Effects

Year: 2019

Type: article

Abstract: The application of personalized medicine to psychiatry is challenging. Psychoradiology could provide biomarkers based on objective tests in support of the diagnostic classifications and treatment planning. We review potential psychoradiological biomarkers for psychopharmaceutical effects. Although none of the biomarkers reviewed are yet of sufficient clinical utility to inform the selection of a specific pharmacologic compound for an individual patient, there is strong consensus that advanced multimodal approaches will contribute to discovery of novel treatment predictors in psychiatric disorders. Progress has been sufficient to warrant enthusiasm, in which application of neuroimaging-based biomarkers would represent a paradigm shift and modernization of psychiatric practice.

Source: Neuroimaging Clinics of North America

DOI: 10.1016/j.nic.2019.09.006

Authors: Anouk Schrantee, Henricus Gerardus Ruhé, Liesbeth Reneman

Institutions: Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Radboud University Nijmegen, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,000